A Clinical Study of TravogenR and TravocortR / TravogenR Therapy in Superficial Fungal Diseases: Multicenter Trials.
- Author:
Do Sik SONG
;
Byung In RO
;
Chin Yo CHANG
;
Kang Woo LEE
;
Kyung Jin RHIM
;
Yong Woo CINN
;
Kyung Sool KWON
;
chang Jo COH
;
Jang Kyu PARK
- Publication Type:Multicenter Study ; Original Article
- MeSH:
Humans;
Trichophyton
- From:Korean Journal of Dermatology
1984;22(3):255-262
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Isoconazole nitrate is one of the broad-spectrum antimycotic agents recently developed from imidazole derivatives. Authors performed ulticenter trials to evaluate the therapeutic effect of Travogen and Travocort in superficial fungal diseases. In the usual superficial fungal diseases, Travogen was applied 4 weeks. In the inflammatory and eczematoid superficial fungal diseases, Travocort was applied 2 weeks initially and then followed by 2 weeks application of Travogen. One hundred and ninty one patients with superficial fungal diseases were included in this study during g months from December, 1982 to August, 19$3 The obtained results were as follows; The overall cure rate of Travogen and Travocort in each superficial fungal diseases were gl 7g (tinea pedis), 98. L% (tinea cruris), 1ppg, (tinea corporis), 9g. 100% (tinea manus), 1ppg (tinea capitis) and 1pgg (candidiasis) respectively. Trichophyton rubrum(51. 3%), Trichophyton mentagrophytes(29.3g), Tricho -countinue-
